Challenges and Opportunities in Pharmaceutical Sector

Janodia, Manthan D and Pandey, Sureshwar and Rao, Venkara J and Sreedhar, D and Ligade, Virendra S and Udupa, N (2008) Challenges and Opportunities in Pharmaceutical Sector. The Internet Journal of Third World Medicine, 7 (1).

[img] PDF
The_Internet_Journal_of_Third_World_Medicine.pdf - Published Version
Restricted to Registered users only

Download (162kB) | Request a copy


TRIPS implementation in India has created much furor within pharmaceutical sector in India. With India adhering to TRIPS requirements it is feared that prices of new drugs in India may shoot up and drugs may become out of reach of common man. But TRIPS agreement provides some inherent flexibilities and with prudent application by the government will benefit the society. Flexibilities like Compulsory Licensing, Parallel Imports, and Bolar Exemption can be used judiciously by Indian government to make drugs affordable to masses. Indian companies have some challenges ahead in product patent regime, as multinational pharma giants will launch products in India from their portfolio of global products, which may have higher prices. Various challenges and opportunities lying ahead in post TRIPS era for Indian pharma industry are discussed.

Item Type: Article
Uncontrolled Keywords: TRIPS, Indian Pharma Industry, Doha Declaration, Compulsory License
Subjects: Pharmacy > MCOPS Manipal > Pharmaceutical Biotechnology
Pharmacy > MCOPS Manipal > Pharmacy Management
Depositing User: KMC Manipal
Date Deposited: 20 Feb 2012 05:07
Last Modified: 20 Feb 2012 05:07

Actions (login required)

View Item View Item